Lenvakast 10mg Capsule

Differentiated Thyroid cancer
Treatment of Kidney Cancer
Liver cancer
Treatment of Endometrial Cancer

The human body shows undesired symptoms after taking the Lenvakast 10mg capsule. Usually, they disappear with time as the body adjusts to the medicine. These side effects don't need special medical attention. It is advised to consult your doctor if these symptoms become unmanageable.
Some of the common side effects of Lenvakast capsule are mentioned below:
Nausea
Fatigue
Diarrhea
Vomiting
Headache
Weight loss
Loss of appetite
Changes in taste
Joint pain or muscle pain
Stomach pain or discomfort
Hypertension (high blood pressure) Serious side effects:
Blood clotting
Kidney failure
Heart problems
Hypothyroidism
Poor wound healing
Liver toxicity or failure
Hemorrhage (bleeding)
Skin reactions (rash or blisters)

Lenvakast 10mg capsule is a prescription-based anticancer drug that should be administered orally. It is advised to take this capsule after consulting your healthcare expert.

Lenvakast 10mg capsule works by blocking the action of the enzyme Receptor tyrosine kinases (RTKs). This enzyme helps develop new blood vessels that nourish cancer cells and help them multiply. Lenvakast blocks the function of receptors that aid the growth of blood vessels in cancer cells. This helps slow the expansion of the disease to different parts of the body and eventually reduces the size of the tumor.

It is advised not to miss any scheduled dosage of Lenvakast 10mg capsule. In case you miss a dose, consult your doctor immediately.

Don't overdose to compensate for the missed one. Contact your doctor or any healthcare provider and seek medical attention immediately in such cases.

​Go for a healthy and balanced diet while taking this medicine to support overall health and well-being.

It is advised to avoid heavy-duty activities or exercise till the time you get an idea of how Lenvakast is affecting you.

Avoid eating grapefruits or any products which has grapefruit as it affects the absorption rate of Lenvakast 10mg capsule.

It is advised to use effective birth control methods and avoid pregnancy during the treatment with this capsule.

Monitor your blood sugar & pressure, Kidney & Liver function (KFT & LFT), Heart function at proper intervals after taking Lenvakast.

Swelling of hands, lips, and weight gain are some of the side effects observed after taking Lenvakast 10mg capsule. To reduce them, the doctor may suggest some medication.

​
If you experience any kind of symptoms after taking Lenvakast capsules, like unexplained bruising or bleeding, sore throat, mouth ulcers, high temperature (fever), or other signs of infection, it is important to inform your doctor as soon as possible.

At our pharmacy, your health is our top priority. All of our medicines are safe, effective, and approved by leading health authorities. We partner exclusively with reliable and reputable manufacturers, ensuring the highest quality standards in every product we deliver.

Enjoy the convenience of fast home delivery, secure packaging, and affordable prices—plus special discounts on bulk orders. We’re proud to offer international shipping to a wide range of countries across Asia, Europe, Africa, the Americas, and beyond, making trusted healthcare accessible no matter where you are.

Whether you're a patient or a healthcare provider, you can order with confidence and compassion. Our goal is to ensure that quality healthcare reaches everyone, everywhere.


We currently ship to:

Barbados, Haiti, Trinidad and Tobago, Mexico, Bahamas, Ecuador, Peru, Chile, Brazil, Colombia, Philippines, U.K., USA, Kuwait, Saudi Arabia, UAE, Oman, Qatar, Japan, Ireland, Russia, China, France, Australia, Lithuania, Nigeria, Romania, Algeria, Canada, Singapore, Thailand, Hong Kong, Bahrain, Jordan, Indonesia, Hungary, Moldova, Bulgaria, Azerbaijan, Congo, Ethiopia, Lebanon, Morocco, Mozambique, South Korea, Sri Lanka, Belarus, Mongolia, Malaysia, Vietnam, Tunisia, Zambia, and Israel.
Experience the quality everyone’s talking about – order today!

French JD, Haugen BR, Worden FP, Bowles DW, Gianoukakis AG, Konda B, Dadu R, Sherman EJ, McCue S, Foster NR, Nikiforov YE, Farias TDJ, Norman PJ, Wirth LJ.(2024). Combination Targeted Therapy with Pembrolizumab and Lenvatinib in Progressive, Radioiodine-Refractory Differentiated Thyroid Cancers. Clin Cancer Res 30(17), 3757-3767.

Ruicci, K.M., Deng, Y., Xiao, T. et al. Real-world treatment outcomes and clinicopathologic and molecular determinants of response to first-line lenvatinib in patients with advanced follicular cell-derived thyroid cancer. (2025). BJC Rep 41(3).

Sharma, S., Nazar, A. H., Mishra, P., et al. (2025). A new therapeutic paradigm: Radioiodine combined with lenvatinib for radioiodine‑avid metastatic well‑differentiated thyroid cancer. Nuclear Medicine Communications.

Soll, D., Bischoff, P., Frisch, A. et al. (2024). First effectiveness data of lenvatinib and pembrolizumab as first-line therapy in advanced anaplastic thyroid cancer: a retrospective cohort study. BMC Endocr Disord.

Yokota T, Hamauchi S, Kawakami T, Fushiki K. (2024). Lenvatinib rechallenge after failure of lenvatinib and sorafenib in metastatic thyroid cancer. Invest New Drugs 361-368.

Yu, Z., Leng, B., You, R., et al. (2025). Lenvatinib plus immunotherapy versus lenvatinib monotherapy in lenvatinib‑insensitive patients with unresectable hepatocellular carcinoma: A retrospective study. Investigational New Drugs, 43(1), 93–100.